Risk of progression of Barrett's esophagus in patients with cirrhosis

Table 1 Characteristics of Barrett’s esophagus in cirrhotic patients

	No dysplasia (n = 45)	LGD (n = 5)	HGD/cancer (n = 7)	P value
Male	35 (77.8)	3 (60.0)	7 (100.0)	0.24
Age at cirrhosis diagnosis (yr)	57.0 (50, 64)	61 (48, 61)	68 (58, 72)	0.067
Age at BE diagnosis (yr)	57 (52, 64)	57 (50, 62)	67 (61, 71)	0.055
NASH	17 (38.6)	1 (20.0)	2 (28.6)	0.69
Cardiac cirrhosis	9 (20.5)	2 (40.0)	1 (14.3)	0.52
Hypertension	23 (51.1)	2 (40.0)	2 (28.6)	0.63
Diabetes	14 (31.1)	2 (40.0)	2 (28.6)	0.88
Hyperlipidemia	16 (35.6)	2 (40.0)	2 (28.6)	0.99
Varices	13 (28.9)	2 (40.0)	1 (14.3)	0.66
BE Length (cm)	3.3 ± 3.3	5.0 ± 3.7	3.2 ± 4.6	0.58
Presence of hiatal hernia	3 (6.8)	4 (80.0)	2 (28.6)	< 0.0011
Hiatal hernia length	2.7 ± 0.58	4.3 ± 0.96	3.5 ± 0.71	0.11
MELD-Na	10.7 ± 4.5	13.5 ± 10.7	10.8 ± 2.7	0.59
Child-Pugh class A	39	5	6	0.68
Class B	5	0	0
Class C	0	0	1
Follow-up (mo)	34.9 (13.0, 63.7)	44.2 (6.4, 50.6)	13.8 (4.5, 41.0)	0.16

¹Statistically significant; Statistics presented as mean ± SD, Median (P25, P75) or N (column %). BE: Barrett’s esophagus; NASH: Nonalcoholic steatohepatitis; LGD: Low grade dysplasia; HGD: High grade dysplasia; MELD-Na: Model for End-stage Liver Disease-Sodium.